Flavour of the month27 Sep 2016 22:37
An amazing performance here, almost trebling the share price from the 9th September. It's definitely not private investors moving this higher by ramping 👀. There is genuine belief here by the institutional investors that this will come good. Cancer treatment & drug resistant antibiotics is their game. Here we have a strong team entering the Champions League in the competition of who can find a cure for cancer and also by default the Europa League for developing drug resitant antibiotics to fight MRSA and such. 80p looks like the next resistance level after today's 67p resistance level was not broken. Can only see 35p ish as strong support below 67p.
The rise seems to be explained in my mind below...
http://www.proactiveinvestors.co.uk/companies/stocktube/5933/redx-pharma-plc-ready-to-up-its-game-5933.html
<<On Thursday, it announced what chief executive officer Neil Murray described as “quite a coup”, with the appointment of former AstraZeneca luminary Karl Hård as head of investor relations and corporate communications.
Murray tells Proactive Investors the Porcupine programme remains on track, and outlines what’s in store for the next 24 months.
He also explains what Hård’s role will be and what he brings to the company. “The appointment allows us to, dare I say, step up our game in getting our message across to fund managers and investment analysts”, Murray said..>>